Peak6 Investments LLC Intellia Therapeutics, Inc. Call Options Transaction History

Peak6 Investments LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$19.72 - $27.36 $222,836 - $309,168	11,300 Added 66.47%	28,300 $581,000
Q1 2024 May 14, 2024	SELL	$23.82 - $32.8 $214,380 - $295,200	-9,000 Reduced 34.62%	17,000 $467,000
Q4 2023 Feb 13, 2024	BUY	$23.16 - $32.34 $602,160 - $840,840	26,000 New	26,000 $792,000
Q1 2023 May 12, 2023	BUY	$33.3 - $44.82 $249,749 - $336,150	7,500 New	7,500 $279,000
Q2 2022 Aug 12, 2022	BUY	$38.49 - $76.21 $157,809 - $312,461	4,100 Added 21.35%	23,300 $1.21 Million
Q1 2022 May 13, 2022	BUY	$58.27 - $118.99 $1.12 Million - $2.28 Million	19,200 New	19,200 $1.4 Million
Q3 2021 Nov 12, 2021	SELL	$132.37 - $176.78 $2.71 Million - $3.62 Million	-20,500 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$60.88 - $161.91 $1.25 Million - $3.32 Million	20,500 New	20,500 $3.32 Million

314

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $916M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.